Safnelo IV infusion 300mg, manufactured by AstraZeneca, contains anifrolumab (genetical recombination). Anifrolumab is a monoclonal antibody that blocks the type I interferon receptor, reducing inflammatory signals and improving symptoms in adults with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy. It is supplied as a 300mg/2mL/1 bottle injectable drug (YJ code: 3999462A1028).
Safnelo IV infusion 300mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).